aTyr Pharma, Inc.

XNAS

Last traded price · USD

$6.51

+5.27%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:03 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $6.18
Volume: 152
Day's high: —
Day's low: —

In brief

aTyr Pharma, Inc. is a US-listed company listed on Nasdaq, valued at about $16M.
Its shares closed at $6.18 on 4 Nov 2026, down 81.3% over the past year.
From India you can buy ATYR in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy aTyr Pharma, Inc. (ATYR) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole ATYR share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade ATYR options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −45.5% (SPY −1.6%). 3 months: −70.8% (SPY −0.4%). 1 year: −81.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ATYR, SPY · as of 4 Nov 2026
43.1% above its 52-week low
Closed at $6.18 on 4 Nov 2026: 86.1% below the 52-week high of $44.40 (19 Feb 2026) and 43.1% above the low of $4.32 (30 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
5.4 days to cover short interest
10.3M shares were sold short at the 15 Oct 2026 settlement; covering them would take 5.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $6.18 was 49.8% below its 50-day average ($12.31) and 74.1% below its 200-day average ($23.86). It has closed below the 200-day for 288 sessions, since 15 Sep 2025. The 50-day average crossed below the 200-day on 3 Oct 2025, 273 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−45.5%

6 months−85.1%

1 year−81.3%

5 years—

Newswire

About

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Website

Notable moves

May 14, 2026
+41.42%
May 12, 2026
−44.20%
September 15, 2025
−83.17%

aTyr Pharma, Inc.

XNAS

Last traded price · USD

$6.51

+5.27%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:03 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $6.18
Volume: 152
Day's high: —
Day's low: —

In brief

aTyr Pharma, Inc. is a US-listed company listed on Nasdaq, valued at about $16M.
Its shares closed at $6.18 on 4 Nov 2026, down 81.3% over the past year.
From India you can buy ATYR in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy aTyr Pharma, Inc. (ATYR) shares from India?

Do I need the price of a whole ATYR share to invest?

How much can I invest in US stocks in a year?

Can I trade ATYR options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −45.5% (SPY −1.6%). 3 months: −70.8% (SPY −0.4%). 1 year: −81.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ATYR, SPY · as of 4 Nov 2026
43.1% above its 52-week low
Closed at $6.18 on 4 Nov 2026: 86.1% below the 52-week high of $44.40 (19 Feb 2026) and 43.1% above the low of $4.32 (30 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
5.4 days to cover short interest
10.3M shares were sold short at the 15 Oct 2026 settlement; covering them would take 5.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $6.18 was 49.8% below its 50-day average ($12.31) and 74.1% below its 200-day average ($23.86). It has closed below the 200-day for 288 sessions, since 15 Sep 2025. The 50-day average crossed below the 200-day on 3 Oct 2025, 273 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−45.5%

6 months−85.1%

1 year−81.3%

5 years—

Newswire

About

Website

Notable moves

May 14, 2026
+41.42%
May 12, 2026
−44.20%
September 15, 2025
−83.17%

aTyr Pharma, Inc.

aTyr Pharma, Inc. in brief

Behind SPY over 1 year

43.1% above its 52-week low

5.4 days to cover short interest

Below its 50- and 200-day averages

aTyr Pharma, Inc.

aTyr Pharma, Inc. in brief

Behind SPY over 1 year

43.1% above its 52-week low

5.4 days to cover short interest

Below its 50- and 200-day averages